Who to call at Achieve Life Sciences, Inc., and when
Fundz watches for the moments Achieve Life Sciences, Inc. starts buying, and tells you who to reach.
- An alert the day Achieve Life Sciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Achieve Life Sciences, Inc., from your own LinkedIn network
Achieve Life Sciences, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
achievelifesciences.comAI Executive Summary
AI-powered analysis of 8-K filing content
Achieve Life Sciences appointed Benjamin Halladay as Chief Financial Officer effective October 5, 2026, bringing extensive financial leadership experience from his previous role at Esperion Therapeutics to strengthen the company's financial strategy and operations.
Key Takeaways
Benjamin Halladay, age 40, appointed as CFO and principal financial officer effective October 5, 2026
Halladay previously served as CFO at Esperion Therapeutics from November 2022 to September 2026, demonstrating relevant biotech/pharma finance experience
1 more takeaway
Related Filings (1)
1 more filing from Achieve Life Sciences, Inc. in the last 90 days
Filing Overview
What This Means
Achieve Life Sciences, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.